Effect of ABT-263 on Intestinal Fibrosis in Human Myofibroblasts, Human Intestinal Organoids, and the Mouse Salmonella typhimurium Model
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of ABT-263 on Intestinal Fibrosis in Human Myofibroblasts, Human Intestinal Organoids, and the Mouse Salmonella typhimurium Model
Authors
Keywords
-
Journal
INFLAMMATORY BOWEL DISEASES
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2021-07-24
DOI
10.1093/ibd/izab166
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The fate of myofibroblasts during the development of fibrosis in Crohn's Disease
- (2020) Chao Li et al. Journal of Digestive Diseases
- New Therapies in Development for Myelofibrosis
- (2020) Helen T. Chifotides et al. Clinical Lymphoma Myeloma & Leukemia
- Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins
- (2019) Rumani Singh et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Targeting anti-fibrotic pathways in Crohn’s disease – The final frontier?
- (2019) Christopher Ma et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Novel Synergistic Combination of Mitotic Arrest and Promotion of Apoptosis for Treatment of Pancreatic Adenocarcinoma
- (2019) Zhijian Duan et al. Translational Oncology
- Gut Organoids: Mini-Tissues in Culture to Study Intestinal Physiology and Disease
- (2019) Mohammad Almeqdadi et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases
- (2019) Boris Hinz et al. Nature Reviews Rheumatology
- BCL2 Regulates Differentiation of Intestinal Fibroblasts
- (2018) Bruce Weder et al. INFLAMMATORY BOWEL DISEASES
- BH3 mimetics as anti-fibrotic therapy: Unleashing the mitochondrial pathway of apoptosis in myofibroblasts
- (2018) Tobias Kuehl et al. MATRIX BIOLOGY
- Mechanisms, Management, and Treatment of Fibrosis in Patients With Inflammatory Bowel Diseases
- (2017) Florian Rieder et al. GASTROENTEROLOGY
- Targeting senescent cholangiocytes and activated fibroblasts with B-cell lymphoma-extra large inhibitors ameliorates fibrosis in multidrug resistance 2 gene knockout (Mdr2−/− ) mice
- (2017) Anja Moncsek et al. HEPATOLOGY
- Inhibition of Bcl-2/xl With ABT-263 Selectively Kills Senescent Type II Pneumocytes and Reverses Persistent Pulmonary Fibrosis Induced by Ionizing Radiation in Mice
- (2017) Jin Pan et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Targeted apoptosis of myofibroblasts with the BH3 mimetic ABT-263 reverses established fibrosis
- (2017) David Lagares et al. Science Translational Medicine
- The role of myofibroblasts in wound healing
- (2016) B. Hinz Current Research in Translational Medicine
- The BCL-2 protein family, BH3-mimetics and cancer therapy
- (2015) A R D Delbridge et al. CELL DEATH AND DIFFERENTIATION
- Intestinal organoids: A model of intestinal fibrosis for evaluating anti-fibrotic drugs
- (2015) Eva S. Rodansky et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- A phase 2 study of the BH3 mimetic BCL2 inhibitor navitoclax (ABT-263) with or without rituximab, in previously untreated B-cell chronic lymphocytic leukemia
- (2015) Thomas J. Kipps et al. LEUKEMIA & LYMPHOMA
- Matrix Stiffness Corresponding to Strictured Bowel Induces a Fibrogenic Response in Human Colonic Fibroblasts
- (2013) Laura A. Johnson et al. INFLAMMATORY BOWEL DISEASES
- Novel Rho/MRTF/SRF Inhibitors Block Matrix-stiffness and TGF-β–Induced Fibrogenesis in Human Colonic Myofibroblasts
- (2013) Laura A. Johnson et al. INFLAMMATORY BOWEL DISEASES
- ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
- (2013) Andrew J Souers et al. NATURE MEDICINE
- Strategies for anti-fibrotic therapies
- (2012) Joel Rosenbloom et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung Cancer
- (2012) C. M. Rudin et al. CLINICAL CANCER RESEARCH
- CARD-024, a vitamin D analog, attenuates the pro-fibrotic response to substrate stiffness in colonic myofibroblasts
- (2012) Laura A. Johnson et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- NIH Image to ImageJ: 25 years of image analysis
- (2012) Caroline A Schneider et al. NATURE METHODS
- Spironolactone and Colitis: Increased Mortality in Rodents and in Humans
- (2011) Laura A. Johnson et al. INFLAMMATORY BOWEL DISEASES
- Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro
- (2010) Jason R. Spence et al. NATURE
- ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
- (2008) C. Tse et al. CANCER RESEARCH
- Chronic Enteric Salmonella Infection in Mice Leads to Severe and Persistent Intestinal Fibrosis
- (2008) Guntram A. Grassl et al. GASTROENTEROLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started